Notedly, any two subtypes of the catenin-yaps127a-l30p/R34P mutants of NFE2L2 in hepatoblastoma of children are tumorigenic without relying on the activity of KEAP1, providing direct proof of NFE2L2 being an oncoprotein [21]. This evidence concerns the gene NFE2L2 and hepatoblastoma.